Loading...
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium
BACKGROUND: In metastatic renal-cell carcinoma (mRCC), recent data have shown efficacy of first-line ipilimumab and nivolumab (ipi-nivo) as well as immuno-oncology (IO)/vascular endothelial growth factor (VEGF) inhibitor combinations. Comparative data between these strategies are limited. OBJECTIVE:...
Na minha lista:
| Udgivet i: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858928/ https://ncbi.nlm.nih.gov/pubmed/31445844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.07.048 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|